This study was designed to evaluate the cytotoxic and analgesic potential of methanol extracts of five wild mushrooms available in the University of Chittagong, Bangladesh. The acetic acid-induced writhing method was used for the analgesic activity, while cytotoxicity was tested using brine shrimp lethality bioassay.
In silico
molecular docking and ADME/T study have been employed by using Schrodinger v11.1, BIOVIA Discovery Studio 2020 and online tool (AdmeSAR) respectively. The methanol extracts of
Daldinia concentrica
,
Trametes lactinea
,
Fomitopsis cajanderi
and
Daedaleopsis confragosa
exhibited a significant (
p
< 0.001) decrease in the number of writhing when compared to the control group. Except for
Lentinus squarrosulus
at 200 mg/kg body weight, the remaining mushroom extracts showed equal to or above 50 % inhibition of writhing.
Daldinia concentrica
showed the lowest LC
50
values with 0.63 μg/mL, while
Daedaleopsis confragosa
showed the highest LC
50
values of 2.33 μg/mL, indicating decisive cytotoxic action all mushrooms extracts. Considering the secondary metabolites, daldinan A and fomlactone A were found the most promising myco-compounds in analgesic and cytotoxic molecular docking studies. Besides, all the selected metabolites meet the rule of Lipinski's drug-likeliness. These results concluded that each mushroom extracts except
Lentinus squarrosulus
possess a potential analgesic. All the mushroom extracts embrace a promising cytotoxic activity that may guide the progress of a new drug.